Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Flublok vs Licensed IIV in Adults ≥ 50 Years
NCT01825200Phase 3Completed
- Sponsor
- Protein Sciences
- Start
- Mar 2013
- Primary completion
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of influenza vaccine, recombinant hemagglutinin in influenza, sponsored by Protein Sciences. Started Mar 2013; status: completed.
02
Drugs
influenza vaccine, recombinant hemagglutinin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01825200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01825200.